Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA)
These data elucidate real-world utilisation and prescribing patterns of C/T in a diverse patient population with complex medical conditions and various profiles of pathogen resistance between 2016 and 2020.
Authors
- David L. Paterson (ORCID: https://orcid.org/0000-0003-2079-4437)
- Sundeep Kaul
- Àlex Soriano (ORCID: https://orcid.org/0000-0002-9374-0811)
- Emre Yücel (ORCID: https://orcid.org/0000-0002-6036-9526)
- Pierluigi Viale (ORCID: https://orcid.org/0000-0003-1264-0008)
- N Engels (ORCID: https://orcid.org/0000-0002-1807-3465)
- Alexandre H. Watanabe
- Stefan Kluge (ORCID: https://orcid.org/0000-0001-8391-3988)
- Brune Akrich
- Florian Thalhammer (ORCID: https://orcid.org/0000-0001-6523-8229)
- Stephanie Wirbel
- Mike Allen
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Universität Hamburg (DE)
- The University of Queensland (AU)
- Harefield Hospital (GB)
- MSD (UK) Limited (United Kingdom) (GB)
- MSD (France) (FR)
- University Medical Center Hamburg-Eppendorf (DE)
- Martini-Klinik (DE)
- Hospital Clínic de Barcelona (ES)
- Imperial Consultants (GB)
- Zambon (Italy) (IT)
- Medical University of Vienna (AT)
- University of Bologna (IT)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.jgar.2025.01.007
- Citations
- 7
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 8.83